{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:08:16Z","timestamp":1785787696646,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7,27]]},"DOI":"10.1097\/01.tp.0000128628.31556.b1","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T04:05:12Z","timestamp":1090382712000},"page":"264-268","source":"Crossref","is-referenced-by-count":101,"title":["A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications"],"prefix":"10.1097","volume":"78","author":[{"given":"Marzia","family":"Montalbano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy W.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyo","family":"Yamashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Slapak-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emory","family":"Manten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas G.","family":"Tzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00007691-199512000-00019","article-title":"Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.","volume":"17","author":"Sehgal","year":"1995","journal-title":"Therap Drug Monit"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1007\/BF01778320","article-title":"Sirolimus (rapamycin) inhibits mitogen-induced stimulation of protein synthesis in primary lymphocytes.","volume":"44","author":"Bansbach","year":"1995","journal-title":"Inflammation Res"},{"key":"R3-17-20210129","first-page":"985","article-title":"A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.","volume":"28","author":"Brattstrom","year":"1996","journal-title":"Transplant Proc"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jlts.2003.50119","article-title":"A retrospective review of sirolimus(Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.","volume":"9","author":"Neff","year":"2003","journal-title":"Liver Transplant"},{"issue":"Suppl 7","key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1399-0012.16.s7.7.x","article-title":"Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.","volume":"16","author":"Cotterell","year":"2002","journal-title":"Clinical Transplant"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/S0041-1345(98)01301-3","article-title":"Hypertriglyceridemia in renal transplant recipients treated with sirolimus.","volume":"30","author":"Brattstrom","year":"1998","journal-title":"Transplant Proc"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1345\/aph.1A128","article-title":"Delayed wound healing with sirolimus after liver transplant.","volume":"36","author":"Guilbeau","year":"2002","journal-title":"Ann Pharmacotherapy"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/00007890-200005270-00019","article-title":"Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management.","volume":"69","author":"Hong","year":"2000","journal-title":"Transplantation"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archderm.135.5.553","article-title":"Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes.","volume":"135","author":"Kaplan","year":"1999","journal-title":"Arch Dermatol"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200010270-00021","article-title":"Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience.","volume":"70","author":"Dominguez","year":"2000","journal-title":"Transplantation"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-3495(97)78654-5","article-title":"Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12.","volume":"72","author":"Ahern","year":"1997","journal-title":"Biophysical J"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2249.1997.d01-1002.x","article-title":"Effects of rapamycin on apoptosis of rheumatoid synovial cells.","volume":"108","author":"Migita","year":"1997","journal-title":"Clinical Exp Immunol"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-4274(91)90171-2","article-title":"The effect of rapamycin on renal function in the rat: a comparative study with cyclosporine.","volume":"58","author":"Whiting","year":"1991","journal-title":"Toxicol Lett"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200407270-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:14:05Z","timestamp":1785784445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200407270-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,27]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000128628.31556.b1","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7,27]]}}}